Notably, NU-0129, composed of siRNA targeting the GBM oncogene Bcl2Like12 (Bcl2L12) and a gold nanoparticle core, was the first spherical nucleic acid (SNA) drug administered systemically
By subcutaneous injection (Wegovy): initially 0.25 mg once a week and increased every 4 weeks until the full dose of 2.4 mg is reached
doi:10.1001/jamaoncol.2025.2681 Wolff Sagy Y, et al
This tool aims to provide clarity regarding common areas of confusion in clinical practice, helping clinicians to select appropriate individuals with T2D for GLP-1 RA therapies, in line with current available evidence and guidelines
Se recetan nicamente cuando la obesidad representa un riesgo para la salud y cuando otros mtodos, como la dieta y el ejercicio, han fallado en lograr una reduccin de peso sostenible
Is semaglutide the same as Ozempic